Curaleaf Holdings, Inc. filed its 10-Q for the period ending September 30, 2026, reporting 233,672,570 Subordinate Voting Shares outstanding. The filing highlights significant risks including the federal illegality of cannabis in the U.S., potential regulatory changes, and the company's proposed redomicile transaction.
Curaleaf Holdings reported record third-quarter 2026 revenue of $352.7 million, a 10.9% year-over-year increase driven by strong domestic and international growth. Despite the revenue record, the company reported a net loss from continuing operations of $37.4 million for the quarter, while maintaining an adjusted EBITDA margin of 22%.
Term
Q3 2026
“We are building the global leader in cannabis, and our third-quarter results provide further evidence that our strategy is delivering. Solid execution across the business is driving growth, strengthening our competitive position, and advancing our Built for Growth plan.”
Boris Jordan, Chairman and CEO
“These results reflect the disciplined execution of our entire team and reinforce the strength of our global platform. We are translating operational improvements into stronger financial performance, building momentum across the business, and positioning Curaleaf for sustained growth and greater cash generation.”